Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1996Neurology

Complications of intravenous immune globulin treatment in neurologic disease

View Full Paper
Ask AI
Bookmark
Share

Authors

TBThomas H. BrannaganColumbia University Irving Medical CenterKNKeith J. NagleDartmouth CollegeDLDale J. LangeHospital for Special Surgery

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brannagan et al. (1996) studied this question.

synapsesocial.com/papers/6a6c91c5ac440176ef26beb1https://doi.org/10.1212/wnl.47.3.674
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The OPCS: many (more) happy returns?1987 · 7 citations
  2. 2A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy1994 · 473 citations
  3. 3Acute Renal Failure Resulting From Intravenous Immunoglobulin Therapy1993 · 148 citations
  4. 4Halothane–Morphine Compared with High-Dose Sufentanil for Anesthesia and Postoperative Analgesia in Neonatal Cardiac Surgery1992 · 858 citations